Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Battaglin

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
The Lancet. Oncology|January 21, 2023
Mutational analysis of microsatellite-stable gastrointestinal cancer with high tumour mutational burden: a retrospective cohort studyJingyuan Wang, Joanne Xiu, Alex Farrell, et al.
European Journal of Cancer (Oxford, England : 1990)|August 13, 2025
Outcomes for FOLFIRI plus bevacizumab or cetuximab in patients treated with oxaliplatin-based adjuvant therapy: A combined analysis of FIRE-3 and CALGB/SWOG 80405 (Alliance)Francesca Battaglin, Bert H O'Neil, Sebastian Stintzing, et al.
Oncogene|August 24, 2025
GABAergic signaling contributes to tumor cell invasion and poor overall survival in colorectal cancerCarly Strelez, Francesca Battaglin, Rachel Perez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2021
The Landscape of Alterations in DNA Damage Response Pathways in Colorectal CancerHiroyuki Arai, Andrew Elliott, Joanne Xiu, et al.
The Oncologist|February 17, 2018
Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic ChemotherapyValentina Fanotto, Mario Uccello, Irene Pecora, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2022
Multi-omic Characterization of Pancreatic Ductal Adenocarcinoma Relates CXCR4 mRNA Expression Levels to Potential Clinical TargetsFlorian Kocher, Alberto Puccini, Gerold Untergasser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2016
Reliable Detection of Mismatch Repair Deficiency in Colorectal Cancers Using Mutational Load in Next-Generation Sequencing PanelsZsofia K Stadler, Francesca Battaglin, Sumit Middha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 7, 2022
Comprehensive Analysis of R-Spondin Fusions and RNF43 Mutations Implicate Novel Therapeutic Options in Colorectal CancerAndreas Seeber, Francesca Battaglin, Kai Zimmer, et al.
Oncogene|November 3, 2021
Molecular characteristics and clinical outcomes of patients with Neurofibromin 1-altered metastatic colorectal cancerHiroyuki Arai, Andrew Elliott, Joshua Millstein, et al.
Journal for Immunotherapy of Cancer|January 11, 2024
<i>CCR5</i> and <i>CCL5</i> gene expression in colorectal cancer: comprehensive profiling and clinical valueFrancesca Battaglin, Yasmine Baca, Joshua Millstein, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
The Lancet. Oncology|January 21, 2023
Mutational analysis of microsatellite-stable gastrointestinal cancer with high tumour mutational burden: a retrospective cohort studyJingyuan Wang, Joanne Xiu, Alex Farrell, et al.
European Journal of Cancer (Oxford, England : 1990)|August 13, 2025
Outcomes for FOLFIRI plus bevacizumab or cetuximab in patients treated with oxaliplatin-based adjuvant therapy: A combined analysis of FIRE-3 and CALGB/SWOG 80405 (Alliance)Francesca Battaglin, Bert H O'Neil, Sebastian Stintzing, et al.
Oncogene|August 24, 2025
GABAergic signaling contributes to tumor cell invasion and poor overall survival in colorectal cancerCarly Strelez, Francesca Battaglin, Rachel Perez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2021
The Landscape of Alterations in DNA Damage Response Pathways in Colorectal CancerHiroyuki Arai, Andrew Elliott, Joanne Xiu, et al.
The Oncologist|February 17, 2018
Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic ChemotherapyValentina Fanotto, Mario Uccello, Irene Pecora, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2022
Multi-omic Characterization of Pancreatic Ductal Adenocarcinoma Relates CXCR4 mRNA Expression Levels to Potential Clinical TargetsFlorian Kocher, Alberto Puccini, Gerold Untergasser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2016
Reliable Detection of Mismatch Repair Deficiency in Colorectal Cancers Using Mutational Load in Next-Generation Sequencing PanelsZsofia K Stadler, Francesca Battaglin, Sumit Middha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 7, 2022
Comprehensive Analysis of R-Spondin Fusions and RNF43 Mutations Implicate Novel Therapeutic Options in Colorectal CancerAndreas Seeber, Francesca Battaglin, Kai Zimmer, et al.
Oncogene|November 3, 2021
Molecular characteristics and clinical outcomes of patients with Neurofibromin 1-altered metastatic colorectal cancerHiroyuki Arai, Andrew Elliott, Joshua Millstein, et al.
Journal for Immunotherapy of Cancer|January 11, 2024
<i>CCR5</i> and <i>CCL5</i> gene expression in colorectal cancer: comprehensive profiling and clinical valueFrancesca Battaglin, Yasmine Baca, Joshua Millstein, et al.
Pageof 9